Korea Arlico Pharm Co.,Ltd.

Informe acción KOSDAQ:A260660

Capitalización de mercado: ₩79.4b

Korea Arlico PharmLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Hang-Gu Lee

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO39.2%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Mar 24
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Mar 02
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

Feb 12
Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Jan 25
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Jan 04
Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Dec 16
Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

CEO

Hang-Gu Lee (62 yo)

no data

Permanencia

Mr. Hang-Gu Lee is Chief Executive Officer of Korea Arlico Pharm Co.,Ltd.